IPO · GKSL

Gujarat Kidney and Super Speciality IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹114.00₹108 to ₹114
Listing gain+5.3%at the opening price
Since the IPO+33.1%₹151.71 on 18 Nov
Subscribed5.21×times in total

Gujarat Kidney and Super Speciality IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Gujarat Kidney and Super Speciality came to the market at ₹114.00 a share (price band ₹108 to ₹114), with bidding open from 22 December to 24 December 2025. It listed on NSE on Tuesday, 30 December 2025, opening at ₹120.00, a gain of 5.3% on the issue price, and closed the first day -8.3% from the issue price after trading between -9.7% and +7.9%. 39% of the first day’s traded shares were taken for delivery.

The issue was subscribed 5.21× in total, institutions (QIB) 1.06×, HNIs (NII) 5.73×, retail investors 19.0×. Across the 31 IPOs subscribed 3–10×, the median listing gain was +4.4%.

Its listing gain beat 42% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 6 months after listing it was +13.1% from the issue price and +23.3% from the first-day close, while NIFTY 50 moved -5.9% over the same days. Its highest price so far was 84% above the issue price (1 Oct 2026) and its lowest 14% below it (23 Jan 2026); it closed below the issue price on 35% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹11430 Dec 202518 Nov 2026₹152

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)1.06×
Non-institutional (NII / HNI)5.73×
NII, bids above ₹10 lakh5.25×
NII, ₹2–10 lakh6.68×
Retail investors19.0×
Total5.21×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Tuesday 30 December 2025.

Open+5.3%vs issue price
High / low+8% / -10%vs issue price
Close-8.3%vs issue price
Delivery39%₹343 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week6 Jan 2026-11.5%-3.5%+0.9%+8.0%
1 month30 Jan 2026-7.8%+0.6%-2.4%+9.4%
3 months2 Apr 2026-9.0%-0.7%-12.4%+10.3%
6 months7 Jul 2026+13.1%+23.3%-5.9%+8.0%

IPO details

From NSE’s issue page.

Company
Gujarat Kidney and Super Speciality
NSE symbol
GKSL
Board
Main board
Industry
Hospital
Bidding
22 Dec – 24 Dec 2025
Price band
₹108 to ₹114
Issue price
₹114.00
Issue size
Initial Public Offer comprising Fresh Issue up to 2,20,00,000 Equity Shares. (Including Anchor investors portion of 87,73,120 Equity Shares)
Bid lot
128 Equity Shares and in multiples thereof
Listing date
30 December 2025
ISIN
INE0V0W01025

Gujarat Kidney and Super share price, delivery & results →How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Gujarat Kidney and Super Speciality IPO?
Gujarat Kidney and Super Speciality listed on 30 December 2025 and opened +5.3% against its issue price of ₹114.00; it closed the first day -8.3% from the issue price.
What is the Gujarat Kidney and Super Speciality share price now against the IPO price?
At the close of 18 November 2026, Gujarat Kidney and Super Speciality was at ₹151.71, +33.1% from the IPO price of ₹114.00.
How many times was the Gujarat Kidney and Super Speciality IPO subscribed?
Gujarat Kidney and Super Speciality’s IPO was subscribed 5.21× in total; QIB 1.06×; NII 5.73×; retail 19.0× (NSE + BSE bids, as reported by NSE).
When was the Gujarat Kidney and Super Speciality IPO open?
Bidding ran from 22 December to 24 December 2025 at a price band of ₹108 to ₹114; the shares listed on 30 December 2025.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.